TL;DR
This study introduces a novel Respiratory Aerosol Sampling Chamber (RASC) to capture and analyze airborne Mycobacterium tuberculosis (Mtb) from untreated TB patients. The RASC system successfully detected Mtb in the majority of patients' exhaled aerosols, with molecular detection (ddPCR) proving significantly more sensitive than traditional culture methods, highlighting the potential for new diagnostic and transmission research tools.
What Problem Does This Paper Address?
Tuberculosis (TB) is primarily an airborne disease, yet understanding the precise mechanisms of its transmission through exhaled aerosols has been a major challenge. Quantifying and characterizing the Mycobacterium tuberculosis (Mtb) bacilli within these bio-aerosols is difficult due to low concentrations, contamination issues, and the need to differentiate between viable and non-viable bacteria. Existing methods struggle to capture and analyze these aerosols effectively, hindering research into infectiousness and transmission dynamics. This paper aims to address this gap by developing and applying a system to quantitatively analyze Mtb in exhaled bio-aerosols from newly diagnosed TB patients.
Methods
The core of this research is the Respiratory Aerosol Sampling Chamber (RASC), a custom-built 1.4 m³ clean-room designed for patient confinement. The RASC incorporates several advanced features:
- Aerodynamic Particle Size Detection: An APS (Model 3321) measures particle sizes in real-time.
- Viable and Non-Viable Sampling: Various devices, including a six-stage viable Andersen Impactor and polycarbonate filters, are used to capture particles for both microbiological culture and molecular analysis.
- Real-time CO₂ Monitoring: Used to estimate the volume of exhaled air.
- Cough Sound Recording: A microphone and custom software analyze cough frequency and duration.
After sampling, Mtb detection was performed using two primary methods:
- Microbiological Culture: Using Middlebrook 7H10 agar, incubated for 4-6 weeks.
- Droplet Digital Polymerase Chain Reaction (ddPCR): A highly sensitive molecular technique to detect Mtb DNA.
Datasets
The study utilized data from 35 newly diagnosed, GeneXpert sputum-positive, drug-susceptible TB patients. These patients were recruited from a peri-urban township near Cape Town, South Africa. No external datasets were used for training or evaluation; the study generated its own data through direct sampling and analysis of these participants.
Key Insights and Ideas
- Bio-aerosols are a significant Mtb reservoir: The RASC system successfully detected Mtb in a high percentage (77.1%) of exhaled aerosol samples from untreated TB patients, underscoring the importance of airborne transmission.
- Molecular detection reigns supreme: ddPCR was significantly more sensitive (92.96% positive) than traditional culture (42.8% positive), suggesting that a substantial portion of detected Mtb DNA may come from non-culturable or non-viable bacilli. This raises questions about what exactly is being detected and its implications for infectivity.
- Particle size matters, but not exclusively: Mtb was detected across various particle sizes, with a peak concentration in the 2.0-3.5 µm range, consistent with inhalable particles. However, detection occurred on all impactor stages, indicating Mtb is present in a range of aerosol sizes.
- Coughing is linked to culturable aerosols: A correlation was found between higher cough rates and the presence of culturable Mtb in aerosols, reinforcing the role of coughing in expelling infectious particles.
- High concentrations in aerosols: The estimated median concentration of Mtb in exhaled particulate bio-aerosol was remarkably high (4.5x10⁷ CFU/ml), suggesting that aerosols may be a more concentrated source of Mtb than sputum.
Key Results
- Overall Mtb detection: 27 out of 35 (77.1%) patients had Mtb detected in their aerosol samples.
- Culture positivity: 15 out of 35 (42.8%) samples were positive by mycobacterial culture.
- ddPCR positivity: 25 out of 27 (92.96%) tested samples were positive by ddPCR.
- Median culturable aerosol concentration: 0.09 CFU/litre of exhaled air.
- Median bio-aerosol concentration: 4.5x10⁷ CFU/ml.
- Correlation: A significant correlation was found between cough rate and culturable bio-aerosol.
Limitations and Future Work
The authors acknowledge several limitations:
- Small sample size: The study involved 35 patients, all with drug-susceptible TB. Future studies need to confirm these findings in larger, more diverse populations, including those with drug-resistant TB.
- ddPCR sensitivity criteria: Stringent criteria were used for ddPCR to ensure high specificity, which may have come at the cost of sensitivity.
- Fungal and bacterial contamination: Despite HEPA filtration, contamination was observed, and the source (environmental vs. patient sputum) could not be definitively determined without sputum cultures for fungi and bacteria.
- DNA vs. viable bacilli: The high ddPCR positivity compared to culture raises questions about the proportion of viable, non-culturable, or dead bacilli in aerosols. Further research is needed to differentiate these.
Future work suggested includes:
- Augmenting culture methods: Exploring more sensitive liquid capture and culture techniques.
- Investigating cell-free DNA: Determining if Mtb DNA signals in ddPCR originate from viable or non-viable cells, or cell-free DNA.
- Clinical application: Refining the RASC system for potential use as a non-invasive diagnostic test, especially for sputum-scarce or smear-negative patients.
- Understanding cough's role: Further investigating whether coughing is essential for producing infectious aerosols.
- Real-life conditions: Assessing RASC performance in more complex "real-life" transmission scenarios.
Summary updated